|
DE226590C
(enExample)
|
|
|
|
|
|
DE258226C
(enExample)
|
|
|
|
|
|
DE276479C
(enExample)
|
|
|
|
|
|
NL218146A
(enExample)
|
1956-02-13 |
1900-01-01 |
|
|
|
BE787576A
(fr)
|
1971-08-13 |
1973-02-14 |
Hoechst Ag |
Derives de benzofuranne et leur utilisation comme azureurs optiques
|
|
BE787580A
(fr)
|
1971-08-13 |
1973-02-14 |
Hoechst Ag |
Procede de preparation de derives du furanne
|
|
GB1409865A
(en)
|
1973-02-13 |
1975-10-15 |
Science Union & Cie |
Dihydropyridines derivatives their preparation and pharmaceu tical compositions containing them
|
|
US4062858A
(en)
|
1976-12-22 |
1977-12-13 |
E. R. Squibb & Sons, Inc. |
Derivatives of 5,6-dihydrobenzo[5,6]cyclohepta[1,2-b]pyrazolo[4,3-e]pyridin-11(1H)-ones and 11(1H)-imines
|
|
GB1593417A
(en)
|
1976-12-22 |
1981-07-15 |
Squibb & Sons Inc |
Carbocyclic-fused pyrazolopyridine derivatives
|
|
DE2964427D1
(en)
|
1978-10-04 |
1983-02-03 |
Ciba Geigy Ag |
Process for the preparation of furanyl-benzazoles
|
|
DE2853765A1
(de)
|
1978-12-13 |
1980-06-26 |
Bayer Ag |
Verfahren zur herstellung von benzimidazolylbenzofuranen
|
|
DE2904829A1
(de)
|
1979-02-08 |
1980-08-14 |
Bayer Ag |
Verfahren zur herstellung von benzimidazolylbenzofuran
|
|
HU190774B
(en)
|
1979-06-29 |
1986-11-28 |
The Wellcome Foundation Ltd,Gb |
Process for preparing ether derivatives with pharmacological activity
|
|
GB2090830B
(en)
|
1980-12-18 |
1984-09-26 |
Wellcome Found |
Formyl ether derivatives
|
|
JPS5929667A
(ja)
|
1982-08-13 |
1984-02-16 |
Otsuka Pharmaceut Co Ltd |
カルボスチリル誘導体および強心剤
|
|
US4478834A
(en)
|
1983-02-11 |
1984-10-23 |
Usv Pharmaceutical Corporation |
Dihydropyridines and their use in the treatment of asthma
|
|
GB8402740D0
(en)
|
1984-02-02 |
1984-03-07 |
Scras |
Furo-(3 4-c)-pyridine derivatives
|
|
JPS6140236A
(ja)
|
1984-08-02 |
1986-02-26 |
Yamanouchi Pharmaceut Co Ltd |
ハイドロキノン誘導体
|
|
DE3431004A1
(de)
|
1984-08-23 |
1986-03-06 |
Hoechst Ag, 6230 Frankfurt |
Neue 3-pyridylverbindungen und verfahren zu ihrer herstellung
|
|
GB8603475D0
(en)
|
1986-02-12 |
1986-03-19 |
Glaxo Group Ltd |
Chemical compounds
|
|
DK111387A
(da)
|
1986-03-05 |
1987-09-06 |
Otsuka Pharma Co Ltd |
Carbostyrilderivater og salte deraf, laegemiddel indeholdende saadanne derivater samt fremgangsmaade til fremstilling af derivaterne
|
|
US4831041A
(en)
|
1986-11-26 |
1989-05-16 |
Fujisawa Pharmaceutical Co., Ltd. |
Imidazopyridine compounds and processes for preparation thereof
|
|
EP0278686A1
(en)
|
1987-02-07 |
1988-08-17 |
The Wellcome Foundation Limited |
Pyridopyrimidines methods for their preparation and pharmaceutical formulations thereof
|
|
JPH07121937B2
(ja)
|
1987-03-18 |
1995-12-25 |
大塚製薬株式会社 |
カルボスチリル誘導体
|
|
JPS63258463A
(ja)
|
1987-04-14 |
1988-10-25 |
Kumiai Chem Ind Co Ltd |
２−フエノキシピリミジン誘導体及び除草剤
|
|
GB8711802D0
(en)
|
1987-05-19 |
1987-06-24 |
Fujisawa Pharmaceutical Co |
Dithioacetal compounds
|
|
GB8718940D0
(en)
|
1987-08-11 |
1987-09-16 |
Glaxo Group Ltd |
Chemical compounds
|
|
US4920131A
(en)
|
1987-11-03 |
1990-04-24 |
Rorer Pharmaceutical Corp. |
Quinoline derivatives and use thereof as antagonists of leukotriene D4
|
|
JP2650038B2
(ja)
|
1988-01-27 |
1997-09-03 |
サントリー株式会社 |
ピロリチジン化合物およびその用途
|
|
EP0336369A1
(en)
|
1988-04-04 |
1989-10-11 |
E.R. Squibb & Sons, Inc. |
3-Acylamino-1-[[[(substituted sulfonyl)amino]carbonyl]amino]2-azetidinones
|
|
US4952574A
(en)
|
1988-09-26 |
1990-08-28 |
Riker Laboratories, Inc. |
Antiarrhythmic substituted N-(2-piperidylmethyl)benzamides
|
|
IE81170B1
(en)
|
1988-10-21 |
2000-05-31 |
Zeneca Ltd |
Pyridine derivatives
|
|
US5236917A
(en)
|
1989-05-04 |
1993-08-17 |
Sterling Winthrop Inc. |
Saccharin derivatives useful as proteolytic enzyme inhibitors and compositions and method of use thereof
|
|
IT1230859B
(it)
|
1989-06-05 |
1991-11-08 |
Corvi Camillo Spa |
2 alchinilfenoli sostituiti ad azione anti infiammatoria, procedimento per la loro preparazione e composizioni farmaceutiche che li contengono.
|
|
EP0453210A3
(en)
|
1990-04-19 |
1993-01-13 |
Imperial Chemical Industries Plc |
Pyridine derivatives
|
|
AU641769B2
(en)
|
1990-06-18 |
1993-09-30 |
Merck & Co., Inc. |
Inhibitors of HIV reverse transcriptase
|
|
CN1034934C
(zh)
|
1990-06-19 |
1997-05-21 |
明治制果株式会社 |
血管紧张素ii拮抗性吡啶衍生物的制备方法
|
|
NL9001752A
(nl)
|
1990-08-02 |
1992-03-02 |
Cedona Pharm Bv |
Nieuwe 1,4-dihydropyridinederivaten.
|
|
IL99731A0
(en)
|
1990-10-18 |
1992-08-18 |
Merck & Co Inc |
Hydroxylated pyridine derivatives,their preparation and pharmaceutical compositions containing them
|
|
US5403816A
(en)
|
1990-10-25 |
1995-04-04 |
Kumiai Chemical Industry Co., Ltd. |
Picolinic acid derivative and herbicidal composition
|
|
JPH05301872A
(ja)
|
1992-04-23 |
1993-11-16 |
Kumiai Chem Ind Co Ltd |
ピコリン酸誘導体及び除草剤
|
|
AU1183992A
(en)
|
1991-02-08 |
1992-09-07 |
Byk Gulden Lomberg Chemische Fabrik Gmbh |
Complexing agents
|
|
JPH0641118A
(ja)
|
1991-05-31 |
1994-02-15 |
Kumiai Chem Ind Co Ltd |
ピコリン酸誘導体及び除草剤
|
|
US5185251A
(en)
|
1991-06-07 |
1993-02-09 |
Merck & Co., Inc. |
Microbial transformation of a substituted pyridinone using actinoplanacete sp. MA 6559
|
|
JP2600644B2
(ja)
|
1991-08-16 |
1997-04-16 |
藤沢薬品工業株式会社 |
チアゾリルベンゾフラン誘導体
|
|
FR2680512B1
(fr)
|
1991-08-20 |
1995-01-20 |
Adir |
Nouveaux derives de 2,4-thiazolidinedione, leur procede de preparation et les compositions pharmaceutiques qui les contiennent.
|
|
US5202243A
(en)
|
1991-10-04 |
1993-04-13 |
Merck & Co., Inc. |
Method of hydroxylating 3-[2-(benzoxazol-2-yl)ethyl]-5-ethyl-6-methyl-2-(1H)-pyridinone by incubation with liver slices
|
|
GB9203798D0
(en)
|
1992-02-21 |
1992-04-08 |
Fujisawa Pharmaceutical Co |
Quinolylbenzofuran derivatives,processes for preparation thereof and pharmaceutical composition comprising the same
|
|
WO1994001406A1
(de)
|
1992-07-01 |
1994-01-20 |
Byk Gulden Lomberg Chemische Fabrik Gmbh |
Kontrastmittel für die mr diagnostik
|
|
US5290941A
(en)
|
1992-10-14 |
1994-03-01 |
Merck & Co., Inc. |
Facile condensation of methylbenzoxazoles with aromatic aldehydes
|
|
HU224548B1
(hu)
|
1993-04-07 |
2005-10-28 |
Taiho Pharmaceutical Co. Ltd. |
Tiazolidinszármazékok és ezeket tartalmazó gyógyszerkészítmények, valamint eljárás előállításukra
|
|
DE4318550A1
(de)
|
1993-06-04 |
1994-12-08 |
Boehringer Mannheim Gmbh |
Aryliden-4-oxo-2-thioxo-3- thiazolidincarbonsäuren, Verfahren zu ihrer Herstellung und diese Verbindungen enthaltende Arzneimittel
|
|
AU672699B2
(en)
|
1993-06-30 |
1996-10-10 |
Sankyo Company Limited |
Amide and urea derivatives having anti-hypercholesteremic activity, their preparation and their therapeutic uses
|
|
JPH0725882A
(ja)
|
1993-07-07 |
1995-01-27 |
Res Dev Corp Of Japan |
アクロメリン酸ｂおよびｅを製造するための中間体と、その製造方法
|
|
DE69418789T2
(de)
|
1993-08-05 |
1999-12-02 |
Hoechst Marion Roussel, Inc. |
2-(Piperidin-4-yl, Pyridin-4-yl und Tetrahydropyridin-4-yl)-benzofuran-7-carbamat Derivate, ihre Herstellung und Verwendung als Acetylcholinesterase Inhibitoren
|
|
EP0640609A1
(en)
|
1993-08-24 |
1995-03-01 |
Ono Pharmaceutical Co., Ltd. |
Fused phenol derivatives having inhibitory activity on TXA2 synthetase, and 5-lipoxygenase and scavenging activity on oxygen species
|
|
US5880131A
(en)
|
1993-10-20 |
1999-03-09 |
Enzon, Inc. |
High molecular weight polymer-based prodrugs
|
|
US5965566A
(en)
|
1993-10-20 |
1999-10-12 |
Enzon, Inc. |
High molecular weight polymer-based prodrugs
|
|
US5840900A
(en)
|
1993-10-20 |
1998-11-24 |
Enzon, Inc. |
High molecular weight polymer-based prodrugs
|
|
US5605976A
(en)
|
1995-05-15 |
1997-02-25 |
Enzon, Inc. |
Method of preparing polyalkylene oxide carboxylic acids
|
|
WO1995014015A1
(en)
|
1993-11-19 |
1995-05-26 |
Ciba-Geigy Ag |
Benzothiophene derivatives possessing a methoxyimino substituent as microbicides
|
|
EP0658559A1
(de)
|
1993-12-14 |
1995-06-21 |
Chemisch Pharmazeutische Forschungsgesellschaft m.b.H. |
Thienothiazinderivate, Verfahren zu ihrer Herstellung und ihre Verwendung als 5-dipoxygenase und Cyclooxygenaseinhibitoren
|
|
HUT74385A
(en)
|
1994-02-14 |
1996-12-30 |
Merrell Pharma Inc |
Novel mercaptoacetylamido 1,3,4,5-tetrahydro-benzo[c]azepin-3-one disulfide derivatives useful as inhibitors of enkephalinase and ace
|
|
GB9420557D0
(en)
|
1994-10-12 |
1994-11-30 |
Zeneca Ltd |
Aromatic compounds
|
|
DE4442050A1
(de)
|
1994-11-25 |
1996-05-30 |
Hoechst Ag |
Heterospiroverbindungen und ihre Verwendung als Elektrolumineszenzmaterialien
|
|
US5650408A
(en)
|
1995-06-07 |
1997-07-22 |
Karanewsky; Donald S. |
Thiazolo benzazepine containing dual action inhibitors
|
|
TW434240B
(en)
|
1995-06-20 |
2001-05-16 |
Zeneca Ltd |
Aromatic compounds, preparation thereof and pharmaceutical composition comprising same
|
|
JP3895404B2
(ja)
|
1996-05-17 |
2007-03-22 |
興和株式会社 |
カルコン誘導体及びこれを含有する医薬
|
|
WO1997041120A1
(en)
|
1996-07-26 |
1997-11-06 |
Dr. Reddy's Research Foundation |
Thiazolidinedione compounds having antidiabetic, hypolipidaemic, antihypertensive properties, process for their preparation and pharmaceutical compositions thereof
|
|
US6630496B1
(en)
|
1996-08-26 |
2003-10-07 |
Genetics Institute Llc |
Inhibitors of phospholipase enzymes
|
|
CA2264020A1
(en)
|
1996-08-26 |
1998-03-05 |
Jean Bemis |
Inhibitors of phospholipase enzymes
|
|
WO1998009967A1
(fr)
|
1996-09-09 |
1998-03-12 |
Kyowa Hakko Kogyo Co., Ltd. |
Derives de pyrrolocarbazole
|
|
BR9713027A
(pt)
|
1996-11-12 |
2000-01-25 |
Novartis Ag |
Derivados de pirazol úteis como herbicidas
|
|
US6043389A
(en)
|
1997-03-11 |
2000-03-28 |
Mor Research Applications, Ltd. |
Hydroxy and ether-containing oxyalkylene esters and uses thereof
|
|
US5760232A
(en)
|
1997-06-16 |
1998-06-02 |
Schering Corporation |
Synthesis of intermediates useful in preparing bromo-substituted tricyclic compounds
|
|
US6214817B1
(en)
|
1997-06-20 |
2001-04-10 |
Monsanto Company |
Substituted pyridino pentaazamacrocyle complexes having superoxide dismutase activity
|
|
US6011042A
(en)
|
1997-10-10 |
2000-01-04 |
Enzon, Inc. |
Acyl polymeric derivatives of aromatic hydroxyl-containing compounds
|
|
US6111107A
(en)
|
1997-11-20 |
2000-08-29 |
Enzon, Inc. |
High yield method for stereoselective acylation of tertiary alcohols
|
|
HUP0301166A2
(en)
|
1997-12-12 |
2003-08-28 |
Euro Celtique Sa |
3-substituted adenines via2-thioxanthines
|
|
KR20010041346A
(ko)
|
1998-02-25 |
2001-05-15 |
브루스 엠. 에이센, 토마스 제이 데스로저 |
포스포리파제 ａ2 억제제
|
|
JP2002506873A
(ja)
|
1998-03-18 |
2002-03-05 |
アリアド・ファーマシューティカルズ・インコーポレイテッド |
複素環式シグナル伝達阻害剤、それを含む組成物
|
|
US6214879B1
(en)
|
1998-03-24 |
2001-04-10 |
Virginia Commonwealth University |
Allosteric inhibitors of pyruvate kinase
|
|
US6153655A
(en)
|
1998-04-17 |
2000-11-28 |
Enzon, Inc. |
Terminally-branched polymeric linkers and polymeric conjugates containing the same
|
|
GB9810860D0
(en)
|
1998-05-20 |
1998-07-22 |
Hoechst Schering Agrevo Gmbh |
Substituted pyridine and pyrimidines, processes for their preparation and their use as pesticides
|
|
US6232320B1
(en)
|
1998-06-04 |
2001-05-15 |
Abbott Laboratories |
Cell adhesion-inhibiting antiinflammatory compounds
|
|
IL139811A0
(en)
|
1998-06-04 |
2002-02-10 |
Abbott Lab |
Cell adhesion-inhibiting antinflammatory compounds
|
|
GB9818627D0
(en)
|
1998-08-26 |
1998-10-21 |
Glaxo Group Ltd |
Improvements in dva vaccination
|
|
GB9823871D0
(en)
|
1998-10-30 |
1998-12-23 |
Pharmacia & Upjohn Spa |
2-Amino-thiazole derivatives, process for their preparation, and their use as antitumour agents
|
|
US20030060425A1
(en)
*
|
1998-11-24 |
2003-03-27 |
Ahlem Clarence N. |
Immune modulation method using steroid compounds
|
|
HRP20010427A2
(en)
|
1998-12-14 |
2002-06-30 |
Hoffmann La Roche |
Phenylglycine derivatives
|
|
EP1150957A1
(en)
|
1998-12-31 |
2001-11-07 |
Aventis Pharmaceuticals Inc. |
N-carboxymethyl substituted benzolactams as inhibitors of matrix metalloproteinase
|
|
US6544980B2
(en)
|
1998-12-31 |
2003-04-08 |
Aventis Pharmaceuticals Inc. |
N-carboxymethyl substituted benzolactams as inhibitors of matrix metalloproteinase
|
|
JP2002541134A
(ja)
|
1999-03-31 |
2002-12-03 |
ビーエーエスエフ アクチェンゲゼルシャフト |
置換アニリン化合物
|
|
US6251927B1
(en)
|
1999-04-20 |
2001-06-26 |
Medinox, Inc. |
Methods for treatment of sickle cell anemia
|
|
WO2000069472A2
(en)
|
1999-05-14 |
2000-11-23 |
Boehringer Ingelheim Pharmaceuticals, Inc. |
Enzyme-activated anti-tumor prodrug compounds
|
|
US6184228B1
(en)
|
1999-05-25 |
2001-02-06 |
Anadys Pharmaceuticals, Inc. |
Anti-sickling agents: selection methods and effective compounds
|
|
HK1045306A1
(zh)
|
1999-06-03 |
2002-11-22 |
Abbott Laboratories |
抑制细胞黏附的抗炎化合物
|
|
AUPQ105499A0
(en)
|
1999-06-18 |
1999-07-08 |
Biota Scientific Management Pty Ltd |
Antiviral agents
|
|
EA005027B1
(ru)
|
1999-06-28 |
2004-10-28 |
Янссен Фармацевтика Н.В. |
Ингибиторы репликации респираторно-синцитиального вируса
|
|
US6599917B1
(en)
|
1999-09-28 |
2003-07-29 |
Eisai Co., Ltd. |
Quinuclidine compounds and drugs containing the same as the active ingredient
|
|
AU2622301A
(en)
|
1999-11-05 |
2001-05-14 |
Emisphere Technologies, Inc. |
Phenyl amine carboxylic acid compounds and compositions for delivering active agents
|
|
AUPQ407699A0
(en)
|
1999-11-16 |
1999-12-09 |
Fujisawa Pharmaceutical Co., Ltd. |
Aminoalcohol derivatives
|
|
NZ519984A
(en)
|
2000-01-07 |
2004-03-26 |
Transform Pharmaceuticals Inc |
High-throughput formation, identification, and analysis of diverse solid-forms
|
|
AU2001230537A1
(en)
|
2000-02-01 |
2001-08-14 |
Daiichi Pharmaceutical Co., Ltd. |
Pyridoxazine derivatives
|
|
US6506755B2
(en)
|
2000-02-03 |
2003-01-14 |
Hoffmann-La Roche Inc. |
Thiazolidinecarboxyl acids
|
|
AUPQ585000A0
(en)
|
2000-02-28 |
2000-03-16 |
Fujisawa Pharmaceutical Co., Ltd. |
Aminoalcohol derivatives
|
|
WO2001070663A2
(en)
|
2000-03-17 |
2001-09-27 |
Corixa Corporation |
Novel amphipathic aldehydes and their use as adjuvants and immunoeffectors
|
|
AUPQ841300A0
(en)
|
2000-06-27 |
2000-07-20 |
Fujisawa Pharmaceutical Co., Ltd. |
New aminoalcohol derivatives
|
|
CA2415890C
(en)
|
2000-07-14 |
2009-04-07 |
F. Hoffmann-La Roche Ag |
N-oxides as nk1 receptor antagonist prodrugs of 4-phenyl-pyridine derivatives
|
|
AU2001281071A1
(en)
|
2000-08-01 |
2002-02-13 |
Gmp Companies, Inc. |
Ammonium salts of hemoglobin allosteric effectors, and uses thereof
|
|
US6653313B2
(en)
|
2000-08-10 |
2003-11-25 |
Warner-Lambert Company Llc |
1,4-dihydropyridine compounds as bradykinin antagonists
|
|
JP4272338B2
(ja)
|
2000-09-22 |
2009-06-03 |
バイエル アクチェンゲゼルシャフト |
ピリジン誘導体
|
|
AUPR034000A0
(en)
|
2000-09-25 |
2000-10-19 |
Fujisawa Pharmaceutical Co., Ltd. |
Aminoalcohol derivatives
|
|
IL155702A0
(en)
|
2000-11-20 |
2003-11-23 |
Biovitrum Ab |
Piperazinylpyrazine compounds as agonist or antagonist of serotonin 5-ht2 receptor
|
|
WO2002051849A1
(en)
|
2000-12-26 |
2002-07-04 |
Daiichi Pharmaceutical Co., Ltd. |
Cdk4 inhibitors
|
|
ATE433964T1
(de)
|
2000-12-28 |
2009-07-15 |
Takeda Pharmaceutical |
Alkansäurederivate, verfahren zu deren herstellung und deren verwendung
|
|
US20030022923A1
(en)
|
2001-03-01 |
2003-01-30 |
Medinox, Inc. |
Methods for treatment of sickle cell anemia
|
|
US6627646B2
(en)
|
2001-07-17 |
2003-09-30 |
Sepracor Inc. |
Norastemizole polymorphs
|
|
EP1435894A4
(en)
|
2001-07-23 |
2005-07-06 |
Galileo Pharmaceuticals Inc |
CYTOPROTECTIVE COMPOUNDS, PHARMACEUTICAL AND COSMETIC FORMULATIONS AND METHOD
|
|
JP2003075970A
(ja)
|
2001-08-31 |
2003-03-12 |
Konica Corp |
ハロゲン化銀カラー写真感光材料、カラー写真感光材料、その画像形成方法及びデジタル画像情報作製方法
|
|
KR100467313B1
(ko)
|
2001-11-22 |
2005-01-24 |
한국전자통신연구원 |
적색 유기 전기발광 화합물 및 그 제조 방법과 전기발광소자
|
|
GB0128499D0
(en)
|
2001-11-28 |
2002-01-23 |
Merck Sharp & Dohme |
Therapeutic agents
|
|
US20030187026A1
(en)
|
2001-12-13 |
2003-10-02 |
Qun Li |
Kinase inhibitors
|
|
MXPA04005864A
(es)
|
2001-12-19 |
2004-10-29 |
Atherogenics Inc |
Derivados de charcona y su uso para tratar enfermedades.
|
|
US20030190333A1
(en)
|
2002-02-04 |
2003-10-09 |
Corixa Corporation |
Immunostimulant compositions comprising aminoalkyl glucosaminide phosphates and saponins
|
|
EP1542704A1
(en)
|
2002-04-18 |
2005-06-22 |
Stephen H. Embury |
Method and composition for preventing pain in sickle cell patients
|
|
US6608076B1
(en)
|
2002-05-16 |
2003-08-19 |
Enzon, Inc. |
Camptothecin derivatives and polymeric conjugates thereof
|
|
GB0212785D0
(en)
|
2002-05-31 |
2002-07-10 |
Glaxo Group Ltd |
Compounds
|
|
BR0313160A
(pt)
|
2002-08-08 |
2005-07-12 |
Smithkline Beecham Corp |
Composto, composição farmacêutica, métodos para tratar uma condição e um neoplasmo suscetìvel em um animal em um animal, processo para preparar um composto e uso de um composto
|
|
AU2003257666A1
(en)
|
2002-08-23 |
2004-03-11 |
Kirin Beer Kabushiki Kaisha |
COMPOUND HAVING TGFss INHIBITORY ACTIVITY AND MEDICINAL COMPOSITION CONTAINING THE SAME
|
|
WO2004024705A1
(ja)
|
2002-09-10 |
2004-03-25 |
Takeda Pharmaceutical Company Limited |
５員複素環化合物
|
|
AU2003296022B2
(en)
|
2002-12-04 |
2007-01-25 |
Virginia Commonwealth University |
Anti-sickling agents
|
|
AU2003303239A1
(en)
|
2002-12-19 |
2004-07-14 |
Atherogenics, Inc. |
Process of making chalcone derivatives
|
|
WO2004058790A1
(ja)
|
2002-12-25 |
2004-07-15 |
Kissei Pharmaceutical Co., Ltd. |
含窒素複素環誘導体、それを含有する医薬組成物およびその医薬用途
|
|
WO2004073675A1
(de)
|
2003-02-24 |
2004-09-02 |
Randolph Riemschneider |
Kosmetische zusammensetzung mit whitening-effekt, verfahren zu ihrer herstellung und ihre verwendung
|
|
US20040186077A1
(en)
|
2003-03-17 |
2004-09-23 |
Medicure International Inc. |
Novel heteroaryl phosphonates as cardioprotective agents
|
|
ZA200507752B
(en)
|
2003-03-28 |
2007-01-31 |
Threshold Pharmaceuticals Inc |
Compositions and methods for treating cancer
|
|
EP1613613B1
(en)
|
2003-04-11 |
2021-06-02 |
Genzyme Corporation |
Cxcr4 chemokine receptor binding compounds
|
|
RU2337908C2
(ru)
|
2003-06-12 |
2008-11-10 |
Ново Нордиск А/С |
Пиридинилкарбаматы в качестве ингибиторов гормон-чувствительной липазы
|
|
WO2005019220A2
(en)
|
2003-08-11 |
2005-03-03 |
Cellular Genomics Inc. |
Substituted imidazo[1,2-a]pyrazines as modulators of kinase activity
|
|
US7411083B2
(en)
|
2003-09-25 |
2008-08-12 |
Wyeth |
Substituted acetic acid derivatives
|
|
BRPI0416283A
(pt)
|
2003-11-05 |
2007-01-23 |
Hoffmann La Roche |
compostos, processo para a fabricação de compostos, composição farmacêutica, método para o tratamento e/ou prevenção de doenças que são moduladas por agonistas de ppar(delta) e/ou ppar(alfa) e uso destes compostos
|
|
AU2004289690A1
(en)
|
2003-11-10 |
2005-05-26 |
Schering Aktiengesellschaft |
Benzylether amine compounds useful as CCR-5 antagonists
|
|
EP1694328A4
(en)
|
2003-12-02 |
2010-02-17 |
Celgene Corp |
METHOD AND COMPOSITIONS FOR THE TREATMENT AND SUPPLY OF HEMOGLOBINOPATHY AND ANEMIA
|
|
US7378439B2
(en)
|
2004-01-20 |
2008-05-27 |
Usv, Ltd. |
Process for the preparation of 4-(2-dipropylaminoethyl)-1,3-dihydro-2H-indol-2-one hydrochloride
|
|
AU2005211349A1
(en)
|
2004-01-30 |
2005-08-18 |
Istituto Di Ricerche Di Biologia Molecolare P. Angeletti S.P.A. |
N-benzyl-3,4-dihyroxypyridine-2-carboxamide and N-benzyl-2,3-dihydroxypyridine-4-carboxamide compounds useful as HIV integrase inhibitors
|
|
GB0403038D0
(en)
|
2004-02-11 |
2004-03-17 |
Novartis Ag |
Organic compounds
|
|
WO2005087766A1
(en)
|
2004-03-09 |
2005-09-22 |
Istituto Di Ricerche Di Biologia Molecolare P Angeletti Spa |
Hiv integrase inhibitors
|
|
WO2005086951A2
(en)
|
2004-03-10 |
2005-09-22 |
Threshold Pharmaceuticals, Inc. |
Hypoxia-activated anti-cancer agents
|
|
DE102004015226B3
(de)
|
2004-03-24 |
2005-08-25 |
Siemens Ag |
Verfahren zum Plasmareinigen eines Werkstücks und zu dessen Durchführung geeignete Vorrichtung
|
|
JP2007534691A
(ja)
*
|
2004-04-22 |
2007-11-29 |
アロス・セラピューティクス・インコーポレーテッド |
アロステリックヘモグロビン修飾体の組成物および前記組成物の製造法
|
|
TW200606133A
(en)
|
2004-06-30 |
2006-02-16 |
Sankyo Co |
Substituted benzene compounds
|
|
TW200606129A
(en)
|
2004-07-26 |
2006-02-16 |
Chugai Pharmaceutical Co Ltd |
Novel cyclohexane derivative, its prodrug, its salt and diabetic therapeutic agent containing the same
|
|
GB0420722D0
(en)
|
2004-09-17 |
2004-10-20 |
Addex Pharmaceuticals Sa |
Novel allosteric modulators
|
|
CA2585165A1
(en)
|
2004-10-28 |
2006-05-18 |
Medicure International Inc. |
Dual antiplatelet/anticoagulant pyridoxine analogs
|
|
EP1831170A4
(en)
|
2004-12-14 |
2009-10-14 |
Astrazeneca Ab |
SUBSTITUTED AMINOPYRIDINES AND THEIR USE
|
|
US7968574B2
(en)
|
2004-12-28 |
2011-06-28 |
Kinex Pharmaceuticals, Llc |
Biaryl compositions and methods for modulating a kinase cascade
|
|
ATE516026T1
(de)
|
2005-02-21 |
2011-07-15 |
Shionogi & Co |
Bicyclisches carbamoylpyridonderivat mit hiv- integrase-hemmender wirkung
|
|
EP1861357B1
(en)
|
2005-03-19 |
2013-04-24 |
Amorepacific Corporation |
Novel compounds or pharmaceutically acceptable salts thereof as vanilloid receptor antagonist; and pharmaceutical compositions containing the same
|
|
WO2006106711A1
(ja)
|
2005-03-30 |
2006-10-12 |
Eisai R & D Management Co., Ltd. |
ピリジン誘導体を含有する抗真菌剤
|
|
GB0506677D0
(en)
|
2005-04-01 |
2005-05-11 |
Btg Int Ltd |
Iron modulators
|
|
DK1874117T3
(da)
|
2005-04-28 |
2013-09-23 |
Viiv Healthcare Co |
Polycyklisk carbamoylpyridonderivat med hiv-integrasehæmmende aktivitet
|
|
DE102005025989A1
(de)
|
2005-06-07 |
2007-01-11 |
Bayer Cropscience Ag |
Carboxamide
|
|
JP2006342115A
(ja)
|
2005-06-10 |
2006-12-21 |
Shionogi & Co Ltd |
Ｈｉｖインテグラーゼ阻害活性を有する多環性化合物
|
|
EP2308840A1
(en)
|
2005-06-30 |
2011-04-13 |
Prosidion Limited |
GPCR agonists
|
|
CN100562514C
(zh)
|
2005-07-22 |
2009-11-25 |
中国科学院上海药物研究所 |
一类取代丙酰胺衍生物、其制备方法和用途
|
|
GB0516270D0
(en)
|
2005-08-08 |
2005-09-14 |
Glaxo Group Ltd |
Novel compounds
|
|
SI1945622T1
(sl)
|
2005-10-11 |
2012-05-31 |
Univ Pittsburgh |
Izotopično markirane spojine benzfurana kot označevalne snovi za amiloidogenske proteine
|
|
JP5131689B2
(ja)
|
2005-10-27 |
2013-01-30 |
塩野義製薬株式会社 |
Ｈｉｖインテグラーゼ阻害活性を有する多環性カルバモイルピリドン誘導体
|
|
WO2007061923A2
(en)
|
2005-11-18 |
2007-05-31 |
Takeda San Diego, Inc. |
Glucokinase activators
|
|
WO2007084914A2
(en)
|
2006-01-17 |
2007-07-26 |
Neurocrine Biosciences, Inc. |
Phenoxy-substituted pyrimidines as adenosine receptor antagonists
|
|
WO2007095495A2
(en)
|
2006-02-13 |
2007-08-23 |
Pharmacopeia, Inc. |
Benzodiazepine gcnf modulators for stem cell modulation
|
|
RU2318818C1
(ru)
|
2006-04-12 |
2008-03-10 |
Общество С Ограниченной Ответственностью "Исследовательский Институт Химического Разнообразия" |
Азагетероциклы, комбинаторная библиотека, фокусированная библиотека, фармацевтическая композиция и способ получения (варианты)
|
|
GB0614586D0
(en)
|
2006-07-22 |
2006-08-30 |
Pliva Istrazivacki Inst D O O |
Pharmaceutical Formulation
|
|
CN101113148A
(zh)
|
2006-07-26 |
2008-01-30 |
中国海洋大学 |
二氧哌嗪类化合物及其制备方法和用途
|
|
CA2658925C
(en)
|
2006-07-27 |
2015-07-14 |
Amorepacific Corporation |
Novel sulfonylamino acrylamide derivatives, isomer thereof,or pharmaceutically acceptable salts thereof as vanilloid receptor antagonist; and pharmaceutical compositions containing the same
|
|
TW200817424A
(en)
|
2006-08-04 |
2008-04-16 |
Daiichi Sankyo Co Ltd |
Benzylphenyl glucopyranoside derivatives
|
|
TWI389895B
(zh)
|
2006-08-21 |
2013-03-21 |
Infinity Discovery Inc |
抑制ｂｃｌ蛋白質與結合夥伴間之交互作用的化合物及方法
|
|
CA2661649C
(en)
|
2006-09-03 |
2014-12-30 |
Techfields Biochem Co. Ltd |
Positively charged water-soluble prodrugs of acetaminophen and related compounds with very fast skin penetration rate
|
|
JP2010505811A
(ja)
|
2006-10-04 |
2010-02-25 |
ファイザー・プロダクツ・インク |
カルシウム受容体アンタゴニストとしてのピリド［４，３−ｄ］ピリミジン−４（３Ｈ）−オン誘導体
|
|
MX2009004385A
(es)
|
2006-10-23 |
2009-05-22 |
Merck & Co Inc |
Derivados de 2-[1-fenil-5-hidroxi-4alfa-metil-hexahidrociclopenta [f]indazol-5-il]etil fenilo como ligandos del receptor glucocorticoide.
|
|
TW200835687A
(en)
|
2006-11-30 |
2008-09-01 |
R Tech Ueno Ltd |
Thiazole derivatives and their use as VAP-1 inhibitor
|
|
FR2909379B1
(fr)
|
2006-11-30 |
2009-01-16 |
Servier Lab |
Nouveaux derives heterocycliques,leur procede de preparation et les compositions pharmaceutiques qui les contiennent.
|
|
EP2123637A4
(en)
|
2006-11-30 |
2011-12-21 |
Tokyo Inst Tech |
NEW CURCUMIN DERIVATIVES
|
|
WO2008101682A2
(en)
|
2007-02-22 |
2008-08-28 |
Syngenta Participations Ag |
Iminipyridine derivatives and their uses as microbiocides
|
|
TWI407960B
(zh)
|
2007-03-23 |
2013-09-11 |
Jerini Ag |
小分子緩激肽ｂ２受體調節劑
|
|
CN101679172B
(zh)
|
2007-05-22 |
2013-05-29 |
住友化学株式会社 |
苯甲醛化合物的制造方法
|
|
WO2009001214A2
(en)
|
2007-06-28 |
2008-12-31 |
Pfizer Products Inc. |
Thieno[2,3-d]pyrimidin-4(3h)-one, isoxazolo[5,4-d]pyrimidin-4(5h)-one and isothiazolo[5,4-d]pyrimidin-4(5h)-one derivatives as calcium receptor antagonists
|
|
WO2009011850A2
(en)
|
2007-07-16 |
2009-01-22 |
Abbott Laboratories |
Novel therapeutic compounds
|
|
KR101158191B1
(ko)
*
|
2007-07-17 |
2012-06-19 |
에프. 호프만-라 로슈 아게 |
11ｂ-하이드록시스테로이드 탈수소효소의 억제제
|
|
ATE522249T1
(de)
|
2007-07-26 |
2011-09-15 |
Novartis Ag |
Organische verbindungen
|
|
TW200918521A
(en)
|
2007-08-31 |
2009-05-01 |
Astrazeneca Ab |
Heterocyclic amides and methods of use thereof
|
|
JP5456681B2
(ja)
|
2007-10-17 |
2014-04-02 |
ノバルティス アーゲー |
ＡＬＫ阻害剤として有用なイミダゾ［１，２−ａ］ピリジン誘導体
|
|
JP5301557B2
(ja)
|
2007-12-04 |
2013-09-25 |
エフ．ホフマン−ラ ロシュ アーゲー |
イソオキサゾロ−ピリジン誘導体
|
|
US7776875B2
(en)
|
2007-12-19 |
2010-08-17 |
Hoffman-La Roche Inc. |
Spiroindolinone derivatives
|
|
JP2009203230A
(ja)
|
2008-01-31 |
2009-09-10 |
Daiichi Sankyo Co Ltd |
ベンジルフェニルグルコピラノシド誘導体を含有する医薬組成物
|
|
US8258349B2
(en)
|
2008-02-14 |
2012-09-04 |
Suitomo Chemical Company, Limited |
Process for production of benzaldehyde compound
|
|
US8633245B2
(en)
|
2008-04-11 |
2014-01-21 |
Institute Of Medicinal Molecular Design, Inc. |
PAI-1 inhibitor
|
|
BRPI0906348A2
(pt)
|
2008-04-11 |
2019-07-16 |
Inst Of Medicinal Molecular Designer Inc |
composto representado pela fórmula (1), composição farmacêutica; inibidor pai-1 e medicamento para prevenção para prevenção e/ou tratamento terapêutico de doença causada pela manifestação de pai-1 ou pelo aumento da ação de pai-1
|
|
JP2011136906A
(ja)
|
2008-04-18 |
2011-07-14 |
Otsuka Pharmaceut Co Ltd |
複素環化合物
|
|
US8119647B2
(en)
|
2008-04-23 |
2012-02-21 |
Glenmark Pharmaceuticals S.A. |
Fused pyrimidineone compounds as TRPV3 modulators
|
|
CA2723233C
(en)
|
2008-05-08 |
2017-06-13 |
Nova Southeastern University |
Specific inhibitors for vascular endothelial growth factor receptors
|
|
WO2009146555A1
(en)
|
2008-06-04 |
2009-12-10 |
Ambrilia Biopharma Inc. |
Hiv integrase inhibitors from pyridoxine
|
|
DE102008027574A1
(de)
|
2008-06-10 |
2009-12-17 |
Merck Patent Gmbh |
Neue Pyrrolidinderivate als MetAP-2 Inhibitoren
|
|
JP5314330B2
(ja)
|
2008-06-16 |
2013-10-16 |
住友化学株式会社 |
２−（アリールオキシメチル）ベンズアルデヒドの製造方法およびその中間体
|
|
GB0811451D0
(en)
|
2008-06-20 |
2008-07-30 |
Syngenta Participations Ag |
Novel microbiocides
|
|
AR073304A1
(es)
|
2008-09-22 |
2010-10-28 |
Jerini Ag |
Moduladores del receptor de bradiquinina b2 de molecula pequena
|
|
JP2012508692A
(ja)
|
2008-11-12 |
2012-04-12 |
シェーリング コーポレイション |
脂肪酸結合タンパク質（ｆａｂｐ）の阻害薬
|
|
TW201033201A
(en)
|
2009-02-19 |
2010-09-16 |
Hoffmann La Roche |
Isoxazole-isoxazole and isoxazole-isothiazole derivatives
|
|
HUE049450T2
(hu)
|
2009-03-31 |
2020-09-28 |
Ligand Pharm Inc |
Endotelin és angiotenzin II receptor antagonista bifenilszulfonamid glomeruloszklerózis és IgA által kiváltott nefropátia kezelésére
|
|
ES2440000T3
(es)
|
2009-05-08 |
2014-01-27 |
Tetraphase Pharmaceuticals, Inc. |
Compuestos de 8-aza-tetraciclina
|
|
EP2471789B9
(en)
*
|
2009-08-26 |
2015-03-25 |
Takeda Pharmaceutical Company Limited |
Fused heterocyclic ring derivative and use thereof
|
|
EP2474540A4
(en)
|
2009-08-31 |
2013-03-13 |
Nippon Chemiphar Co |
GPR119 AGONIST
|
|
BR112012005616A2
(pt)
|
2009-09-21 |
2016-06-21 |
Hoffmann La Roche |
compostos antivirais heterocíclicos
|
|
NZ599763A
(en)
|
2009-11-09 |
2014-06-27 |
Wyeth Llc |
Tablet formulations of neratinib maleate
|
|
TW201139406A
(en)
|
2010-01-14 |
2011-11-16 |
Glaxo Group Ltd |
Voltage-gated sodium channel blockers
|
|
KR101698153B1
(ko)
|
2010-04-26 |
2017-01-23 |
광주과학기술원 |
Ｐ2ｘ1 및 ｐ2ｘ3 수용체 길항제로 사용되는 신규한 피리딘 카르복실산계 화합물, 이의 제조방법 및 이를 포함하는 조성물
|
|
CN102232949A
(zh)
|
2010-04-27 |
2011-11-09 |
孙远 |
提高药物溶出度的组合物及其制备方法
|
|
TWI535442B
(zh)
|
2010-05-10 |
2016-06-01 |
Kyowa Hakko Kirin Co Ltd |
A nitrogen-containing heterocyclic compound having an action of inhibiting the production of canine erythritine
|
|
US20120122928A1
(en)
|
2010-08-11 |
2012-05-17 |
Bayer Cropscience Ag |
Heteroarylpiperidine and -Piperazine Derivatives as Fungicides
|
|
CN102116772B
(zh)
|
2010-09-28 |
2013-08-28 |
上海大学 |
二氢查尔酮化合物的筛选方法
|
|
JP2014501224A
(ja)
|
2010-12-27 |
2014-01-20 |
武田薬品工業株式会社 |
口腔内崩壊錠
|
|
BR112013025680A2
(pt)
*
|
2011-04-06 |
2017-01-03 |
Teva Pharma |
Novos intermediários e processos para preparar ticagrelor
|
|
CN103717588B
(zh)
|
2011-04-11 |
2016-08-03 |
绿色科技株式会社 |
吡唑衍生物
|
|
PE20142353A1
(es)
|
2011-09-15 |
2015-01-10 |
Demerx Inc |
Ansolvatos de sal de noribogaina
|
|
US20140308260A1
(en)
|
2011-10-07 |
2014-10-16 |
Radiorx, Inc. |
Methods and compositions comprising a nitrite-reductase promoter for treatment of medical disorders and preservation of blood products
|
|
CA3142817A1
(en)
|
2011-12-28 |
2013-07-04 |
Global Blood Therapeutics, Inc. |
Substituted benzaldehyde compounds and methods for their use in increasing tissue oxygenation
|
|
ES2790358T3
(es)
|
2011-12-28 |
2020-10-27 |
Global Blood Therapeutics Inc |
Compuestos de heteroaril aldehído sustituido y métodos para su uso en el aumento de la oxigenación tisular
|
|
BR112015015216B1
(pt)
*
|
2012-12-27 |
2020-01-07 |
Sumitomo Chemical Company, Limited |
Composto de tetrazolinona, agente e método de controle de peste
|
|
US9802900B2
(en)
|
2013-03-15 |
2017-10-31 |
Global Blood Therapeutics, Inc. |
Bicyclic heteroaryl compounds and uses thereof for the modulation of hemoglobin
|
|
EP3919056B1
(en)
|
2013-03-15 |
2024-08-28 |
Global Blood Therapeutics, Inc. |
Compounds and uses thereof for the modulation of hemoglobin
|
|
US20150057251A1
(en)
|
2013-08-26 |
2015-02-26 |
Global Blood Therapeutics, Inc. |
Compounds and uses thereof for the modulation of hemoglobin
|
|
CN112500338A
(zh)
|
2013-03-15 |
2021-03-16 |
全球血液疗法股份有限公司 |
化合物及其用于调节血红蛋白的用途
|
|
US9604999B2
(en)
|
2013-03-15 |
2017-03-28 |
Global Blood Therapeutics, Inc. |
Compounds and uses thereof for the modulation of hemoglobin
|
|
CA2902709A1
(en)
|
2013-03-15 |
2014-09-25 |
Global Blood Therapeutics, Inc. |
Compositions and methods for the modulation of hemoglobin (s)
|
|
EP2968299B1
(en)
|
2013-03-15 |
2021-01-20 |
Global Blood Therapeutics, Inc. |
Compounds and uses thereof for the modulation of hemoglobin
|
|
US10100043B2
(en)
|
2013-03-15 |
2018-10-16 |
Global Blood Therapeutics, Inc. |
Substituted aldehyde compounds and methods for their use in increasing tissue oxygenation
|
|
US9422279B2
(en)
|
2013-03-15 |
2016-08-23 |
Global Blood Therapeutics, Inc. |
Compounds and uses thereof for the modulation of hemoglobin
|
|
EA201591427A1
(ru)
|
2013-03-15 |
2016-01-29 |
Глобал Блад Терапьютикс, Инк. |
Соединения и их применения для модуляции гемоглобина
|
|
US8952171B2
(en)
|
2013-03-15 |
2015-02-10 |
Global Blood Therapeutics, Inc. |
Compounds and uses thereof for the modulation of hemoglobin
|
|
US20140271591A1
(en)
|
2013-03-15 |
2014-09-18 |
Global Blood Therapeutics, Inc. |
Compositions and methods for the modulation of hemoglobin (s)
|
|
ES2710380T3
(es)
|
2013-03-15 |
2019-04-24 |
Global Blood Therapeutics Inc |
Compuestos y usos de los mismos para la modulación de hemoglobina
|
|
US9458139B2
(en)
|
2013-03-15 |
2016-10-04 |
Global Blood Therapeutics, Inc. |
Compounds and uses thereof for the modulation of hemoglobin
|
|
US20140274961A1
(en)
|
2013-03-15 |
2014-09-18 |
Global Blood Therapeutics, Inc. |
Compounds and uses thereof for the modulation of hemoglobin
|
|
US10266551B2
(en)
|
2013-03-15 |
2019-04-23 |
Global Blood Therapeutics, Inc. |
Compounds and uses thereof for the modulation of hemoglobin
|
|
US20160206604A1
(en)
|
2013-08-26 |
2016-07-21 |
Global Blood Therapeutics, Inc. |
Formulations comprising wetting agents and compounds for the modulation of hemoglobin (s)
|
|
US20160207904A1
(en)
|
2013-08-27 |
2016-07-21 |
Global Blood Therapeutics, Inc. |
Crystalline 2-hydroxy-6-((2-(1-isopropyl-1h-pyrazol-5-yl)pyridin-3-yl)methoxy)benzaldehyde ansolvate salts
|
|
WO2015031285A1
(en)
|
2013-08-27 |
2015-03-05 |
Global Blood Therapeutics, Inc. |
Crystalline 2-hydroxy-6-((2-(1-isopropyl-1h-pyrazol-5-yl)pyridin-3-yl)methoxy)benzaldehyde ansolvate salts
|
|
EA202092627A1
(ru)
|
2013-11-18 |
2021-09-30 |
Глобал Блад Терапьютикс, Инк. |
Соединения и их применения для модуляции гемоглобина
|
|
US20150141465A1
(en)
|
2013-11-18 |
2015-05-21 |
Global Blood Therapeutics, Inc. |
Compounds and uses thereof for the modulation of hemoglobin
|
|
US9248199B2
(en)
|
2014-01-29 |
2016-02-02 |
Global Blood Therapeutics, Inc. |
1:1 adducts of sickle hemoglobin
|
|
WO2015116061A1
(en)
|
2014-01-29 |
2015-08-06 |
Global Blood Therapeutics, Inc. |
1:1 adducts of sickle hemoglobin
|
|
SG10201911662YA
(en)
|
2014-02-07 |
2020-02-27 |
Global Blood Therapeutics Inc |
Crystalline polymorphs of the free base of 2-hydroxy-6-((2-(1-isopropyl-1h-pyrazol-5-yl)pyridin-3-yl)methoxy)benzaldehyde
|
|
WO2016043849A2
(en)
|
2014-07-24 |
2016-03-24 |
Global Blood Therapeutics, Inc. |
Compounds for treating acute respiratory distress syndrome or a negative effect thereof
|
|
TWI544395B
(zh)
|
2014-09-26 |
2016-08-01 |
義隆電子股份有限公司 |
單層電容式觸控面板之掃描方法及裝置
|
|
MA41841A
(fr)
|
2015-03-30 |
2018-02-06 |
Global Blood Therapeutics Inc |
Composés aldéhyde pour le traitement de la fibrose pulmonaire, de l'hypoxie, et de maladies auto-immunes et des tissus conjonctifs
|
|
HUE072191T2
(hu)
|
2015-12-04 |
2025-10-28 |
Global Blood Therapeutics Inc |
A 2-hidoxi-6-((2-(1-izopropil-1H-pirazol-5-il)piridin-3-il)metoxi)benzaldehid adagolási rendje
|
|
TWI825524B
(zh)
|
2016-05-12 |
2023-12-11 |
美商全球血液治療公司 |
用於合成2-羥基-6-((2-(1-異丙基-1h-吡唑-5-基)-吡啶-3-基)甲氧基)苯甲醛之方法
|
|
TWI778983B
(zh)
|
2016-10-12 |
2022-10-01 |
美商全球血液治療公司 |
包含2-羥基-6-((2-(1-異丙基-1h-吡唑-5-基)吡啶-3-基)甲氧基)-苯甲醛之片劑
|
|
US11014884B2
(en)
|
2018-10-01 |
2021-05-25 |
Global Blood Therapeutics, Inc. |
Modulators of hemoglobin
|
|
CR20210335A
(es)
|
2018-11-19 |
2021-09-14 |
Global Blood Therapeutics Inc |
Compuestos de 2-formil-3-hidroxifeniloximetilo capaces de modular la hemoglobina
|